Cintas Sunflower Rev It Up for Parkinson's Disease This Sunday, Sept. 11
The 11th annual Cintas Sunflower Rev it Up for Parkinsons Disease fundraising event, presented by Montgomery Cyclery and the Deaconess Foundation, will be held beginning at 8 a.m. Sunday, Sept. 11, 2016 at Yeatmans Cove, Sawyer Point Park, in downtown Cincinnati.
Parkinsons disease is a movement disorder affecting as many as one million Americans, with 60,000 new cases diagnosed each year. Funds raised from this event benefit the James J. and Joan A. Gardner Family Center for Parkinsons Disease and Movement Disorders at the University of Cincinnati Gardner Neuroscience Institute, a collaboration of the UC College of Medicine and UC Health.
This year, organizers have planned many features for the event including:
- Dave Parker, a Cincinnati Reds Hall of Famer who was diagnosed with Parkinsons in 2012, will be the Grand Marshal as well as a participant in the event, providing inspiration to all who come out to participate.
- Senator Rob Portman will serve as the honorary chair and will also be a participant. To begin the event, Sen. Portman will pay tribute to the first responders of 9/11.
- At kickoff, from 8 to 9 a.m., the band DFresh will entertain participants and get everyone ready for the athletic activities.
Events will include something for all fitness and age levels, including a 5k walk/run, a 1k walk/wheelchair roll, a 25k family bike ride, a 100k challenging bike ride to Rabbit Hash, Kentucky, and more.
The Be Well Cheetahs, a group of kids from Cincinnati Childrens Hospital Medical Center who have physical challenges, will participating in the 5k walk/run.
The celebration area will have refreshments and DJ entertainment. Some of the participating sponsors include Skyline Chili, JTM Foods, Flip Daddys, Trader Joes, Yankee Doodle Deli, Balance Café, 50West Brewing Company, Starbucks, Curate Snacks, Whole Foods and Infinit Performance.
For more information, visit www.sunflowerrev.org.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.